Who owns Armata Pharmaceuticals Inc?
- Ticker: ARMP
- CUSIP Number: 04216r102
Tip: Access positions for across all investors
Analyze quarterly positions in Armata Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Armata Pharmaceuticals stock
Who bought or sold Armata Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Madison Asset Management | 2.1M | $22M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 366k | $3.7M | 100% | Mar 2026 |
|
| Vanguard Group | 358k | $2.2M | 20% | Dec 2025 |
|
| Millennium Management | 258k | $2.6M | 889% | Mar 2026 |
|
| 683 Capital Management | 137k | $1.4M | -2% | Mar 2026 |
|
| Geode Capital Management | 115k | $1.2M | 4% | Mar 2026 |
|
| Edgewood Management | 100k | $628k | 0% | Dec 2025 |
|
| Sei Investments | 74k | $760k | 100% | Mar 2026 |
|
| Renaissance Technologies | 69k | $430k | 66% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 68k | $695k | 100% | Mar 2026 |
|
| BlackRock | 65k | $666k | -11% | Mar 2026 |
|
| Eudaimonia Asset Management | 61k | $624k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 61k | $624k | 35% | Mar 2026 |
|
| State Street Corporation | 51k | $319k | 26% | Dec 2025 |
|
| Bridgeway Capital Management | 45k | $281k | 0% | Dec 2025 |
|
| SeaCrest Wealth Management | 42k | $425k | 1% | Mar 2026 |
|
| GSB Wealth Management | 30k | $307k | 0% | Mar 2026 |
|
| Jane Street | 28k | $287k | 63% | Mar 2026 |
|
| Northern Trust | 25k | $155k | 28% | Dec 2025 |
|
| Susquehanna International | 24k | $153k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 23k | $147k | 100% | Dec 2025 |
|
| Hudson Bay Capital Management | 18k | $180k | 100% | Mar 2026 |
|
| Captrust Financial Advisors | 13k | $83k | 0% | Dec 2025 |
|
| Bank of America Corporation | 12k | $120k | 100% | Mar 2026 |
|
| Hrt Financial | 11k | $108k | 100% | Mar 2026 |
|
| Dauntless Investment Group | 6.1k | $39k | 100% | Dec 2025 |
|
| Citigroup | 5.2k | $53k | 100% | Mar 2026 |
|
| UBS Group | 4.3k | $45k | 326% | Mar 2026 |
|
| Vanguard Global Advisers | 4.0k | $41k | 100% | Mar 2026 |
|
| Morgan Stanley | 3.4k | $35k | 48% | Mar 2026 |
|
| Tower Research Capital | 1.6k | $10k | 352% | Dec 2025 |
|
| Cornerstone National Bank & Trust | 1.4k | $15k | 0% | Mar 2026 |
|
| Measured Wealth Private Client Group | 1.0k | $10k | 0% | Mar 2026 |
|
| Trifecta Capital Advisors | 714.00 | $7.3k | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 571.00 | $5.8k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 357.00 | $2.2k | -22% | Dec 2025 |
|
| Silver Grove Financial Group | 200.00 | $2.0k | 100% | Mar 2026 |
|
| Whittier Trust | 100.00 | $1.1k | 0% | Mar 2026 |
|
| Salem Investment Counselors | 100.00 | $1.0k | 100% | Mar 2026 |
|
| Geneos Wealth Management | 92.00 | $941.997200 | 0% | Mar 2026 |
|
| Team Financial Group | 71.00 | $726.997400 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 71.00 | $727.998500 | 0% | Mar 2026 |
|
| SBI Securities | 3.00 | $30.999900 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 1.00 | $5.000000 | 0% | Mar 2026 |
|
Who sold out of Armata Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OMERS Administration Corporation | Dec 2025 | 28k | $177k |
| Citadel Advisors | Dec 2025 | 11k | $68k |
| Bnp Paribas Arbitrage, Snc | Dec 2025 | 710.00 | $4.5k |
| Jpmorgan Chase & Co | Sep 2025 | 24.00 | $72.000000 |
| Barclays | Sep 2025 | 6.00 | $18.000000 |